Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-3-18
|
pubmed:abstractText |
Placental site trophoblastic tumor (PSTT) consists of a neoplastic proliferation of intermediate or extravillous trophoblast (also known as X cells). Pregnancy-associated major basic protein (pMBP) is a marker for placental intermediate trophoblast. We compared the distribution of pMBP and human placental lactogen (hPL) in 24 PSTT and 3 exaggerated placental site (EPS) specimens using two distinct immunohistologic methods. Statistical analyses were used to compare staining intensities in metastatic and nonmetastatic lesions. By immunofluorescence, 77% of the PSTT specimens and 100% of the EPS specimens stained with antibodies to pMBP, and the pMBP was localized in intermediate trophoblast and surrounding extracellular areas. By immunohistochemistry, 78% of the PSTT specimens and 100% of the EPS specimens stained for pMBP with a pattern comparable with that of immunofluorescence. Likewise, by immunohistochemistry, hPL stained 96% of the PSTT specimens and 100% of the EPS specimens. Immunohistochemical staining intensities for pMBP and hPL correlated (r2 = +.24; P = .013), but hPL staining was mainly confined to intermediate trophoblast and was more intense. Anti-pMBP tended to stain metastatic PSTT weakly. Thus, pMBP is a useful marker for intermediate trophoblast tumors and could help distinguish these from other forms of trophoblastic disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0046-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
280-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9496832-Adult,
pubmed-meshheading:9496832-Female,
pubmed-meshheading:9496832-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:9496832-Humans,
pubmed-meshheading:9496832-Immunoenzyme Techniques,
pubmed-meshheading:9496832-Middle Aged,
pubmed-meshheading:9496832-Placental Lactogen,
pubmed-meshheading:9496832-Pregnancy,
pubmed-meshheading:9496832-Pregnancy Complications, Neoplastic,
pubmed-meshheading:9496832-Pregnancy-Associated Plasma Protein-A,
pubmed-meshheading:9496832-Trophoblastic Tumor, Placental Site,
pubmed-meshheading:9496832-Tumor Markers, Biological,
pubmed-meshheading:9496832-Uterine Neoplasms
|
pubmed:year |
1998
|
pubmed:articleTitle |
Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers.
|
pubmed:affiliation |
Department of Immunology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|